Table 1 Characteristics and parameters of the 539 HCC patients
Characteristics | no. (%) | 5-year OS (Months) Mean ± SD | p-Value | 5-year DFS (Months) Mean ± SD | p-Value |
|---|---|---|---|---|---|
Gender(n) | |||||
 Male | 480(89.05) | 30.82 ± 20.74 | 0.524 | 30.65 ± 20.71 | 0.566 |
 Female | 59(10.95) | 29.71 ± 20.21 |  | 19.71 ± 20.21 |  |
Age (years) | |||||
  ≥ 53 | 275(51.02) | 32.05 ± 20.57 | 0.167 | 31.75 ± 20.55 | 0.226 |
  < 53 | 264(48.98) | 29.30 ± 20.71 |  | 29.30 ± 20.71 |  |
Stage(n) | |||||
 I and II | 306(56.77) | 38.16 ± 17.84 | < 0.001 | 37.92 ± 17.87 | < 0.001 |
 III and IV | 233(43.23) | 20.90 ± 20.06 |  | 20.87 ± 20.07 |  |
Tumor size(cm) | |||||
  ≥ 5 | 220(40.82) | 20.17 ± 19.68 | < 0.001 | 20.14 ± 19.69 | < 0.001 |
  < 5 | 319(59.18) | 37.96 ± 18.06 |  | 37.73 ± 18.09 |  |
Tumor number | |||||
 Single | 335(62.15) | 33.71 ± 20.02 | 0.001 | 33.55 ± 20.04 | 0.001 |
 Multiple | 192(35.62) | 26.74 ± 20.75 |  | 26.60 ± 20.66 |  |
Node stage | |||||
 N0 | 502(93.14) | 31.35 ± 20.34 | 0.016 | 31.19 ± 20.32 | 0.017 |
 N1–2 | 37(6.86) | 21.92 ± 23.30 |  | 21.92 ± 23.30 |  |
Distant metastases | |||||
 Yes | 31(5.75) | 24.52 ± 23.08 | 0.102 | 24.52 ± 23.08 | 0.108 |
 No | 508(94.25) | 31.08 ± 20.48 |  | 30.92 ± 20.45 |  |
BMI (kg/m2) | |||||
  ≥ 24.0 | 174(32.28) | 32.70 ± 20.70 | 0.234 | 32.44 ± 20.58 | 0.292 |
 18.5–23.9 | 319(59.18) | 29.94 ± 20.74 |  | 29.83 ± 20.77 |  |
  < 18.5 | 45(8.35) | 28.80 ± 19.90 |  | 28.80 ± 19.90 |  |
Alcohol behavior | |||||
 Previous/Current | 200(37.11) | 30.02 ± 21.18 | 0.683 | 29.66 ± 21.08 | 0.535 |
 Never | 339(62.89) | 31.10 ± 20.38 |  | 21.08 ± 20.40 |  |
Family history of cancer | |||||
 Yes | 138(25.60) | 32.21 ± 20.52 | 0.362 | 32.21 ± 20.52 | 0.303 |
 No | 401(74.40) | 30.18 ± 20.72 |  | 29.98 ± 20.68 |  |
HBs Ag | |||||
 Negative | 61 (11.32) | 30.23 ± 19.87 | < 0.001 | 30.22 ± 19.87 | < 0.001 |
 Positive | 362(67.16) | 39.98 ± 18.05 |  | 39.77 ± 18.05 |  |
HBe Ag | |||||
 Negative | 361(66.98) | 31.75 ± 20.65 | 0.283 | 31.56 ± 20.64 | 0.317 |
 Positive | 62(11.50) | 28.44 ± 21.28 |  | 28.44 ± 21.28 |  |
AFP (ng/mL) | |||||
  ≥ 400 | 195(36.18) | 24.35 ± 20.46 | < 0.001 | 24.19 ± 20.40 | < 0.001 |
  < 400 | 323(59.93) | 35.85 ± 19.18 |  | 35.70 ± 19.19 |  |
ALB | |||||
  ≥ 41.35 | 271(50.28%) | 35.40 ± 19.56 | < 0.001 | 35.20 ± 19.58 | < 0.001 |
  < 41.35 | 268(49.72%) | 25.95 ± 20.71 |  | 25.85 ± 20.66 |  |
TBIL | |||||
  ≥ 15.95 | 209(38.78%) | 26.08 ± 21.20 | < 0.001 | 26.02 ± 21.24 | < 0.001 |
  < 15.95 | 330(61.22%) | 33.63 ± 19.80 |  | 33.42 ± 19.78 |  |
HDL(mmol/L) | |||||
  ≥ 1.16 | 253(46.94) | 34.25 ± 19.56 | < 0.001 | 34.00 ± 19.61 | < 0.001 |
  < 1.16 | 286(53.06) | 27.56 ± 21.14 |  | 27.50 ± 21.08 |  |
LDL(mmol/L) | |||||
  ≥ 3.1 | 276(51.21) | 30.72 ± 20.87 | 0.924 | 30.64 ± 20.82 | 0.870 |
  < 3.1 | 263(48.79) | 30.68 ± 20.49 |  | 30.46 ± 20.49 |  |
ApoA-1(g/L) | |||||
  ≥ 1.09 | 279(51.76) | 36.22 ± 19.36 | < 0.001 | 35.99 ± 19.42 | < 0.001 |
  < 1.09 | 260(48.24) | 24.78 ± 20.42 |  | 24.71 ± 20.35 |  |
ApoB(g/L) | |||||
  ≥ 1.1 | 97(18.00) | 29.91 ± 21.97 | 0.717 | 29.87 ± 21.96 | 0.761 |
  < 1.1 | 442(82.00) | 30.88 ± 20.39 |  | 30.70 ± 20.37 |  |
CRP(mg/L) | |||||
  ≥ 3.0 | 290(53.80) | 22.63 ± 20.25 | < 0.001 | 22.57 ± 20.29 | < 0.001 |
  < 3.0 | 249(46.20) | 40.10 ± 16.85 |  | 39.85 ± 16.84 |  |